[96a5a0]: / output / allTrials / identified / NCT03618472_identified.json

Download this file

235 lines (235 with data), 8.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
{
"info": {
"nct_id": "NCT03618472",
"official_title": "Effect of Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells : a Randomized Double Blind Placebo-controlled Trial",
"inclusion_criteria": "* Women with endometrial cancer who undergoing complete surgical staging and agrees to participate in this study\nHealthy volunteers allowed\nMust be FEMALE",
"exclusion_criteria": "* Women without diabetes type 1 and 2\n* Women who have allergy Biguanide\n* Women who have hypoglycemic medication\n* Women who have GFR <45 ml/min/1.73 m2\n* Women who have evidence of stage 3 or 4 of endometrial cancer",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Women with endometrial cancer who undergoing complete surgical staging and agrees to participate in this study",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "endometrial cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "undergoing complete surgical staging",
"criterion": "surgical staging",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "agrees to participate in this study",
"criterion": "study participation",
"requirements": [
{
"requirement_type": "consent",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Women who have allergy Biguanide",
"criterions": [
{
"exact_snippets": "allergy Biguanide",
"criterion": "allergy to Biguanide",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Women who have hypoglycemic medication",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "female"
}
]
},
{
"exact_snippets": "hypoglycemic medication",
"criterion": "medication type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "hypoglycemic"
}
]
}
]
},
{
"line": "* Women who have GFR <45 ml/min/1.73 m2",
"criterions": [
{
"exact_snippets": "GFR <45 ml/min/1.73 m2",
"criterion": "GFR",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 45,
"unit": "ml/min/1.73 m2"
}
}
]
}
]
},
{
"line": "* Women who have evidence of stage 3 or 4 of endometrial cancer",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "female"
}
]
},
{
"exact_snippets": "evidence of stage 3 or 4",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3,
"unit": "stage"
},
{
"operator": "<=",
"value": 4,
"unit": "stage"
}
]
}
}
]
},
{
"exact_snippets": "endometrial cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Women without diabetes type 1 and 2",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "without diabetes type 1",
"criterion": "diabetes type 1",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "without ... type 2",
"criterion": "diabetes type 2",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"failed_miscellaneous": []
}